Holen Sie sich die Stockscreener-App
13.96
0.64%
-0.09
Handel nachbörslich:
14.00
0.04
+0.29%
Clearpoint Neuro Inc Aktie (CLPT) Neueste Nachrichten
ClearPoint Neuro stock slips as revenue misses estimates - AD HOC NEWS
ClearPoint Neuro (CLPT) Stock Sees Fair Value Cut As Analysts Factor In Heavier Investment - Yahoo Finance
ClearPoint Neuro Company Profile & Introduction - Moomoo
How (CLPT) Movements Inform Risk Allocation Models - Stock Traders Daily
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $25 - Moomoo
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024 - ACCESS Newswire
ClearPoint Neuro stock holds recent gains as earnings and analyst targets frame the next move - AD HOC NEWS
ClearPoint (CLPT) Quarter in Focus: The Bottom-Line Figure Trails Its Comparison at the Close; Price Reaction: Shares Finish 11.80% Up on the DaySubscription Growth Report - vinanet.vn
ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Lags Revenue Estimates - Eastern Progress
Conway Capital Management Inc. Makes New $1.66 Million Investment in ClearPoint Neuro, Inc. $CLPT - MarketBeat
ClearPoint Neuro (CLPT) Q2 2026 Earnings Call Transcript - AOL.com
(CLPT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
ClearPoint Neuro (CLPT): MAK Capital group discloses 7.8% ownership in 13G/A - Stock Titan
ClearPoint Neuro (CLPT) Jumps 6.12% to $14.21: Key Levels to WatchRegression Channel - dars.gov.et
ClearPoint Neuro (NASDAQ:CLPT) Downgraded to "Strong Sell" Rating by Wall Street Zen - MarketBeat
Clearpoint Neuro Inc (CLPT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Analysts Have Lowered Expectations For ClearPoint Neuro, Inc. (NASDAQ:CLPT) After Its Latest Results - 富途牛牛
Clearpoint Neuro Inc (CLPT) Stock News Today - TradingKey
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.st
ClearPoint Neuro, Inc. (CLPT) Options Chain - Yahoo! Finance Canada
CLPT Looks 4.6% Overvalued on GF Value™ Ahead of Tuesday Market Drop - GuruFocus
ClearPoint Neuro: Regulatory Momentum Strengthens The Long-Term Investment Case (CLPT) - Seeking Alpha
ClearPoint Neuro Updates Q2 Results and 2026 Outlook - The Globe and Mail
ClearPoint Neuro (CLPT) investors disclose 7.45% beneficial ownership stake - Stock Titan
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Cuts Target Price to $25 - Moomoo
Stifel cuts Clearpoint Neuro stock price target on guidance cut - Investing.com
Stifel cuts Clearpoint Neuro stock price target on guidance cut By Investing.com - Investing.com South Africa
ClearPoint Neuro, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Powell Industries Posts Downbeat Q3 Results, Joins Clearpoint Neuro, Ichor Holdings And Other Big Stocks - Benzinga
CLPT Looks 4.7% Overvalued on GF Value™ - GuruFocus
How Does ClearPoint Neuro Inc (CLPT) Perform in Q2? EPS at -$0.3 - GuruFocus
Earnings call transcript: Clearpoint Neuro Q2 2026 misses estimates as shares fall - Investing.com Canada
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
ClearPoint Neuro Q2 Earnings Call Highlights - Yahoo Finance
Clearpoint Neuro Inc reports results for the quarter ended June 30Earnings Summary - TradingView
ClearPoint Neuro (NASDAQ:CLPT) Issues Quarterly Earnings Results, Misses Estimates By $0.09 EPS - MarketBeat
Transcript : ClearPoint Neuro, Inc., Q2 2026 Earnings Call, Aug 03, 2026 - marketscreener.com
ClearPoint Neuro (CLPT) Stock Falls on Q2 2026 Earnings - Quiver Quantitative
ClearPoint Neuro, Inc. Updates Revenue Guidance for the Year 2026 - marketscreener.com
ClearPoint Neuro Q2 revenue rises 18% but misses estimates - TradingView
ClearPoint Neuro (Nasdaq: CLPT) grows Q2 revenue and updates 2026 outlook - Stock Titan
BRIEF-ClearPoint Neuro Q2 Revenue USD 10.9 Million - tradingview.com
ClearPoint Neuro, Inc. (CLPT) Q2 2026 Earnings - 24/7 Wall St.
ClearPoint Neuro, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
(CLPT) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $30 - Moomoo
CLPT Q1 2026 Earnings: EPS Misses Estimates as Stock Gains 2.47%Quarterly Earnings Report - vinanet.vn
ClearPoint Neuro (CLPT) Gains 2.47% to $14.94 as MedTech Momentum BuildsFactor Valuation - dars.gov.et
CLPT Q2'26 Earnings: EPS estimate is (0.29) USD - TradingView
CLPT Q1 2026 Earnings: Wider Loss of -$0.32 per Share Misses Estimates; Stock Gains 3.11%Earnings Decline Risk - vinanet.vn
Brokers Offer Predictions for CLPT Q2 Earnings - MarketBeat
Clearpoint Neuro Inc (CLPT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BlackRock (CLPT holder) discloses 7.1% beneficial stake in ClearPoint Neuro - Stock Titan
CLPT|Clearpoint Neuro Inc|Price:14.412|Chg%:+0.291 - TradingKey
CLPT|Clearpoint Neuro Inc|Price:14.940|Chg%:+0.360 - TradingKey
CLPT|Clearpoint Neuro Inc|Price:15.310|Chg%:+0.370 - tradingkey.com
Clearpoint Neuro Inc (CLPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CLPT Q1 2026 Earnings: EPS Misses Estimates as Shares Edge LowerPeak Earnings Alert - vinanet.vn
TradingKey - TradingKey
Clearpoint Neuro Inc (CLPT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Clearpoint Neuro Inc (CLPT) Balance Sheet - TradingKey
CLPT|Clearpoint Neuro Inc|Price:15.550|Chg%:-0.390 - TradingKey
Clearpoint Neuro Inc (CLPT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
0.86%
0.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):